Orbital floor reconstruction using calcium phosphate cement paste: an animal study.

Orbital floor defects present a clinical challenge requiring materials that support bone regeneration without adverse effects. Prior research has shown that calcium phosphate cements offer biocompatibility and osteoconductive potential. However, long-term performance in orbital reconstruction remains understudied. This gap motivated an investigation into the behavior of injectable calcium phosphate paste in a controlled animal model. Understanding how implants integrate with surrounding tissues is essential for clinical translation. No prior work had resolved the long-term stability and tissue response to this material in orbital settings. The study aimed to evaluate both structural and biological outcomes over time. These findings could inform material selection for reconstructive procedures.

The goal was to assess the biocompatibility and osteoconductivity of calcium phosphate cement paste in orbital floor reconstruction. A specific problem is the need for materials that maintain structural integrity while supporting tissue regeneration. The study focused on a rabbit model to simulate clinical conditions. Researchers aimed to evaluate tissue response and integration over a 12-month period. The motivation stems from a lack of long-term data on this material in orbital applications. No prior work had resolved the extent of new bone formation and fibrous tissue development. The study sought to determine if this material could serve as a viable reconstructive option. These findings may help guide future clinical use in human patients.

Orbital floor defects were surgically created in 10 New Zealand white rabbits. Each defect was filled with injectable calcium phosphate cement paste. Animals were divided into four groups euthanized at 2, 4, 8, and 12 months post-implantation. Gross examination assessed implant adherence and tissue response. Histological analysis evaluated new bone formation and inflammatory cell presence. Microradiography was used to examine the interface between new bone and the implant. Tissue samples were processed for light microscopy and imaging. These methods provided a comprehensive evaluation of biocompatibility and osteoconductivity.

Implants remained adherent to the orbital floor and were covered with fibrous tissue. No infection, extrusion, or migration was observed in any group. Histological findings showed progressive new bone formation within the implant. Fibrovascular tissues were present on and within the implant surface. Inflammatory cell infiltration was minimal across all time points. Microradiography confirmed direct apposition of new bone to the implant. Maxillary mucosa and glands were reconstituted in all cases. These results suggest favorable integration and tissue compatibility over 12 months.

The authors propose that calcium phosphate paste supports new bone formation and tissue integration in orbital reconstruction. They suggest that the material maintains structural integrity over time. The findings indicate minimal inflammatory response and no adverse effects. The study supports the potential use of this material in clinical settings. The authors believe the ease of use enhances its practical value. These results compare favorably with prior reports on similar materials. The study highlights the importance of long-term evaluation in preclinical models. The authors suggest further investigation in human trials to confirm these outcomes.